Loading...
XSWX
AEVS
Market cap1.18bUSD
Apr 07, Last price  
12.10CHF
1D
0.00%
1Q
-6.92%
Jan 2017
-5.47%
Name

Aevis Victoria SA

Chart & Performance

D1W1MN
P/E
—
P/S
1.11
EPS
—
Div Yield, %
—
Shrs. gr., 5y
1.22%
Rev. gr., 5y
9.64%
Revenues
914m
-11.27%
9,555,000120,073,000119,135,000128,834,000181,485,000200,818,000344,406,000454,669,000484,852,000508,093,000517,115,000582,505,000577,130,000697,234,000696,566,000823,256,0001,030,550,000914,363,000
Net income
-39m
L
-30,867,700-3,232,000164,0001,945,000-7,123,000471,0003,325,0008,675,0006,118,0003,770,0002,309,000-922,000-8,659,000163,195,000-31,795,000-4,265,00058,812,000-39,295,000
CFO
43m
-62.67%
846,0005,568,00010,508,0008,990,00013,601,00012,684,00013,136,00041,674,00018,631,00036,575,00055,600,00060,094,00016,387,00018,862,00023,770,00033,534,000114,300,00042,673,000
Dividend
Sep 28, 20230.3 CHF/sh
Earnings
Sep 04, 2025

Profile

Aevis Victoria SA engages in healthcare, hospitality, lifestyle, and infrastructure sectors in Switzerland. The company operates through Hospitals, Hospitality, Telemedicine, and Real Estate segments. It operates 22 hospitals with 1,496 beds; manages with a total of 941 rooms with a total rentable surface of 188,109 sqm. It also provides telemedicine, and ambulance and day clinic services. In addition, it engages in the patient hotel, better aging, radiology institute, pharmacy, ophthalmology, real estate management, stem cells, cosmetics, and publishing businesses, as well as organizes seminars. The company is headquartered in Fribourg, Switzerland. Aevis Victoria SA is a subsidiary of M.R.S.I. Medical Research, Services and Investments S.A.
URL
https://www.aevis.com/
IPO date
Jul 05, 1999
Employees
3,902
Domiciled in
CH
Incorporated in
CH

Valuation

Title
CHF in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
914,363
-11.27%
1,030,550
25.18%
Cost of revenue
787,741
1,016,084
Unusual Expense (Income)
NOPBT
126,622
14,466
NOPBT Margin
13.85%
1.40%
Operating Taxes
(1,699)
4,679
Tax Rate
32.34%
NOPAT
128,321
9,787
Net income
(39,295)
-166.81%
58,812
-1,478.94%
Dividends
(63,185)
(84,416)
Dividend yield
Proceeds from repurchase of equity
(4,007)
95,561
BB yield
Debt
Debt current
116,386
86,644
Long-term debt
906,265
883,391
Deferred revenue
(61,114)
11,337
Other long-term liabilities
600
2,827
Net debt
698,984
642,375
Cash flow
Cash from operating activities
42,673
114,300
CAPEX
(86,451)
(74,019)
Cash from investing activities
35,564
(56,817)
Cash from financing activities
(72,953)
(45,456)
FCF
88,040
24,786
Balance
Cash
80,706
75,427
Long term investments
242,961
252,233
Excess cash
277,949
276,132
Stockholders' equity
543,365
512,187
Invested Capital
1,262,722
1,205,044
ROIC
10.40%
0.81%
ROCE
7.91%
0.94%
EV
Common stock shares outstanding
84,340
85,512
Price
Market cap
EV
EBITDA
188,559
81,056
EV/EBITDA
Interest
35,072
25,382
Interest/NOPBT
27.70%
175.46%